Colombia, Mexico get more shots
Shipments of Chinese vaccine bolster fight against pandemic in Latin America
Colombia and Mexico welcomed the arrival of their first batches of a Chinese-developed vaccine against COVID-19 over the weekend.
Both Latin American nations received CoronaVac, a vaccine from the Chinese pharmaceutical company Sinovac Biotech.
In Colombia, the arrival of 192,000 doses was greeted with the highest-grade reception at Bogota airport on Saturday, with Colombian President Ivan Duque and VicePresident Marta-Lucia Ramirez among the officials present.
Duque expressed his delight that more vaccines had arrived and voiced his appreciation for China’s support to Colombia in fighting the coronavirus.
He said the vaccines will be “deployed throughout the national territory” including remote regions such as the Amazon.
China’s Ambassador to Colombia, Lan Hu, also on hand for the arrival of the Sinovac shipment, welcome its arrival.
Lan said the fight against the pandemic “has been the priority” of bilateral relations since last year and that the arrival of the vaccine represents an opportunity to help the country return to normality.
“We hope that this vaccine, as a global public good, can play a more positive role in this battle, in this fight, in this national vaccination plan to save more lives and to restore normality to our socioeconomic life as soon as possible.”
Duque said the cooperation between the two countries is yielding more and more fruit as well as greater mutual trust.
Colombia’s National Food and Drug Surveillance Institute approved the emergency use of CoronaVac in early February.
Part of the batch that arrived on
Saturday will be sent to the 48,000 inhabitants of Leticia, the capital of Colombia’s administrative department of the Amazon. The area has been hit hard by a strain of SARSCoV-2 — the virus that causes COVID-19 — first found in South America. The strain, known as P.1, caused large outbreaks of infections in cities such as Manaus, on the Brazilian side of the Amazon jungle.
Mass inoculations
Mass vaccination against COVID-19 began on Thursday in major hospitals in Bogota and other cities. Under Colombia’s national vaccination plan, healthcare workers and older people are among the first groups being immunized. Leticia skips the national queue in an effort to cut the spread of the P.1 strain of the virus in that area.
By Sunday, Colombia had over 2.21 million cases while Mexico had over 2.03 million cases, according to the World Health Organization.
On Saturday, Mexico received its first shipment of 200,000 doses of CoronaVac. A batch of Russia’s Sputnik V vaccine is expected by Monday.
Health officials earlier said the first shipments of the Chinese and Russian vaccines would be used in low-income neighborhoods of Mexico City and its suburbs.
Mexico is currently using vaccines from Pfizer and AstraZeneca and has administered almost 1.6 million doses of those.
The country will now be faced with the logistical challenge of handling four vaccines, all of which require two doses.
On Saturday, Mexican Assistant Health Secretary Hugo Lopez-Gatell tweeted that he had light COVID-19 symptoms on Friday night. He was awaiting the results of a PCR test.
Russia said on Saturday that its scientists had detected the first cases of transmission of the H5N8 strain of avian flu to humans, and the country alerted the World Health Organization.
“Scientists of the Vector Center (the Vector State Virology and Biotechnology Center) isolated the genetic material of this kind of bird flu in seven workers at a poultry farm in the south of the Russian
Federation, where an outbreak in the bird population was recorded in December 2020,” Anna Popova, the head of Russia’s health watchdog Rospotrebnadzor, said in a televised news conference.
The cases amounted to the first known transmission of the H5N8 strain to humans, she said.
Popova said the workers did not suffer any serious health consequences, but all measures for the protection of people and animals were being implemented to minimize any risks.
Russia has sent the WHO information related to the poultry workers found with the virus.
“So far we can see that the novel agent of the H5N8 bird flu is capable of transmission from birds to humans — it crossed the interspecies barrier,” Popova said.
Popova praised “the important scientific discovery”, saying “time will tell” if the virus can further mutate.
“The discovery of these mutations when the virus has not still acquired an ability to transmit from human to human gives us all, the entire world, time to prepare for possible mutations and react in an adequate and timely fashion,” she said.
People can get infected with avian and swine influenza viruses, such as bird flu subtypes H5N1 and H7N9 and swine flu subtypes such as H1N1. People usually get infected through direct contact with animals or contaminated environments, and there is no sustained transmission among humans.
The head of the virology center said it was ready to begin developing test kits and a vaccine.